Interferon-α in combination with either imatinib (Gleevec) or gefitinib (Iressa) in metastatic renal cell carcinoma: a phase II trial

Title
Interferon-α in combination with either imatinib (Gleevec) or gefitinib (Iressa) in metastatic renal cell carcinoma: a phase II trial
Authors
Keywords
-
Journal
ANTI-CANCER DRUGS
Volume 19, Issue 5, Pages 527-533
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2010-02-25
DOI
10.1097/cad.0b013e3282fa4ad2

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search